Latest Updates
Waxman Strategies Publishes White Paper on Nonprofit Pharmaceutical Companies
Based on the input of experts and nonprofit leaders, our white paper describes challenges in five policy areas and provides a set of policy options for policymakers to consider which could improve the sustainability of the nonprofit model and help to reduce the burden of high prescription drug prices.
Read moreWaxman Strategies’ Etelle Higonnet Honored With France’s National Order of Merit
Etelle Higonnet, senior director at Waxman Strategies has been named a Chevalier of France’s Ordre national du Mérite (National Order of Merit) by French President Emmanuel Macron, recognizing her work to protect the environment.
Read moreHenry Waxman Applauds Passage of H.R. 3
Today, the House of Representatives passed H.R. 3 – the Elijah E. Cummings Lower Drug Costs Now Act. Chairman Henry Waxman released the following statement in support of the bill’s passage.
Read moreHow Can We Help?
Are you advancing important solutions? Interested in creating real and lasting change? We want to help.
Let's CollaborateJoin Our Team
Waxman is built on a foundation of experts with the passion and drive to solve the most complex challenges.
Career